These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 920198)

  • 1. Adenylate cyclase activity in corpus striatum of rats with porto-caval anastomosis.
    Laursen H; Klysner R; Geisler A
    Acta Physiol Scand; 1977 Jul; 100(3):282-7. PubMed ID: 920198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of cytosolic modulators of fluoride-stimulated adenylate cyclase activity in striatum and cerebral cortex.
    Rabin RA; Bode DC; Molinoff PB
    Alcohol Drug Res; 1985-1986; 6(6):379-86. PubMed ID: 3836685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
    Gnegy ME; Bernabei A; Treisman G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repartition and drug sensitivity of dopamine and L-isoproterenol-sensitive adenylate cyclases in rat brain homogenates.
    Prémont J; Tassin JP; Thierry AM; Bockaert J
    Adv Biochem Psychopharmacol; 1976; 15():347-56. PubMed ID: 192054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of dopamine-dependent adenylate cyclase by a Ca++ binding protein stored in synaptic membranes.
    Costa E; Gnegy M; Revuelta A; Uzunov P
    Adv Biochem Psychopharmacol; 1977; 16():403-8. PubMed ID: 18889
    [No Abstract]   [Full Text] [Related]  

  • 7. Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration.
    Barnett JV; Kuczenski R
    J Pharmacol Exp Ther; 1986 Jun; 237(3):820-5. PubMed ID: 2940359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of adenylate cyclase by ethanol in mouse striatal tissue.
    Rabin RA; Molinoff PB
    J Pharmacol Exp Ther; 1981 Jan; 216(1):129-34. PubMed ID: 7452500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of adenylate cyclase from rat striatum and tuberculum olfactorium by adenosine.
    Fredholm BB
    Med Biol; 1977 Oct; 55(5):262-7. PubMed ID: 592902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ; Battaglia G; Norman AB; Creese I
    Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective effects of an essential sulfhydryl group on the activation of dopamine- and guanine nucleotide-sensitive adenylate cyclase.
    Suen ET; Kwan PC; Clement-Cormier YC
    Mol Pharmacol; 1982 Nov; 22(3):595-601. PubMed ID: 7155125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of lithium in vitro and in vivo on dopamine-sensitive adenylate cyclase activity in dopaminergic areas of the rat brain.
    Geisler A; Klysner R
    Acta Pharmacol Toxicol (Copenh); 1985 Jan; 56(1):1-5. PubMed ID: 2983514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of functional dependence on ethanol in dopaminergic systems.
    Tabakoff B; Hoffman PL
    J Pharmacol Exp Ther; 1979 Feb; 208(2):216-22. PubMed ID: 570225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra.
    Bockaert J; Premont J; Glowinski J; Tassin JP; Thierry AM
    Adv Biochem Psychopharmacol; 1977; 16():29-37. PubMed ID: 196489
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of evidence for impaired dopamine receptor function in experimental hepatic coma in the rabbit.
    Ferenci P; Jones EA; Hanbauer I
    Neurosci Lett; 1986 Mar; 65(1):60-4. PubMed ID: 3010194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for central hypertyraminemia in hepatic encephalopathy.
    Faraj BA; Camp VM; Ansley JD; Scott J; Ali FM; Malveaux EJ
    J Clin Invest; 1981 Feb; 67(2):395-402. PubMed ID: 7462424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post mortem changes in adenylate cyclase activity in rat brain striatum.
    Witte P; Matthaei H
    Experientia; 1979 Nov; 35(11):1421-2. PubMed ID: 510461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ethanol on Arrhenius parameters and activity of mouse striatal adenylate cyclase.
    Hoffman PL; Tabakoff B
    Biochem Pharmacol; 1982 Oct; 31(19):3101-6. PubMed ID: 7150336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of noradrenaline on the activation and the stability of brain adenylate cyclase.
    Brydon-Golz S; Ohanian H; Bennun A
    Biochem J; 1977 Sep; 166(3):473-83. PubMed ID: 145858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of dopamine-stimulated adenylate cyclase activity by phenoxybenzamine.
    Walton KG; Liepmann P; Baldessarini RJ
    Eur J Pharmacol; 1978 Nov; 52(2):231-4. PubMed ID: 729635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.